{"id":253341,"date":"2015-04-03T06:41:47","date_gmt":"2015-04-03T10:41:47","guid":{"rendered":"http:\/\/www.eugenesis.com\/lutronics-innovative-aesthetic-and-medical-products-featured-at-the-13th-anti-aging-medicine-world-congress\/"},"modified":"2015-04-03T06:41:47","modified_gmt":"2015-04-03T10:41:47","slug":"lutronics-innovative-aesthetic-and-medical-products-featured-at-the-13th-anti-aging-medicine-world-congress","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/anti-aging-medicine\/lutronics-innovative-aesthetic-and-medical-products-featured-at-the-13th-anti-aging-medicine-world-congress.php","title":{"rendered":"LUTRONIC&#039;s Innovative Aesthetic and Medical Products Featured at the 13th Anti-Aging Medicine World Congress"},"content":{"rendered":"<p><p>    Fremont, CA (PRWEB) April 02, 2015  <\/p>\n<p>    Lutronic, a leading innovator of aesthetic and medical    technology, announced today that it expands its portfolio of    innovative medical solutions in Europe with ACTION II Petit    Lady  at the 13th Anti-Aging Medicine World Congress (AMWC) in    Monte-Carlo, Monaco, from March 26-28, 2015. ACTION II is a    device that provides a new dimension in Er:YAG laser technology    applied for both gynecological and aesthetic indications. It    received CE mark clearance for treatment of vaginal relaxation    syndrome (VRS) and stress urinary incontinence (SUI) in June    2014, which expands its clinical applications and builds on the    success of the original ACTION II device which primarily    focused on aesthetic treatments.  <\/p>\n<p>    I have seen that ACTION II Petit Lady increases the elasticity    of the vaginal wall with a significantly short downtime.    Patients suffering from vaginal relaxation syndrome are very    satisfied with Petit Lady because this 15-minute non-surgical    treatment successfully rejuvenates the vagina and enhances    sexual gratification, said Dr Fabio Marini, a surgeon at the    Skin Laser Clinic, in Italy. Dr Marini was presenting on the    Petit Lady system at a special dinner Symposium during the    AMWC, Symposia L, hosted by Lutronic. Dr Marini also    presented his one year clinical study on ACTION II Petit Lady    for vaginal atrophy and vaginal relaxation syndrome, which    showed significant improvements in both sets of patients.  <\/p>\n<p>    The well-attended symposium, which was moderated by Dr R Glen    Calderhead, VP Medicoscientific Affairs for Lutronic, also    featured Dr. Matteo Tretti Clementoni, a plastic surgeon at    Skin House in Italy Dr Clementoni, a world-renowned physician,    shared his knowledge of the INFINI for treating neck and low    face laxity with its High Intensity Focused RF. \"The device is    very easy to use, and it is possible to perform full face and    neck treatment in less than 15 minutes. With varying energy,    pulse duration, depth of needles penetration and number of    passages, it is possible to customize the treatment for the    specific skin needs of each patient on an individual basis.    Finally, we have a device\/treatment that really allows us to    obtain good results on the lower 1\/3 of the face and the neck,    he added. Another presenter of INFINI, Dr Harryono    Judodihardjo, a dermatologist from the Cellite Clinic, UK also    shared his clinical experiences with the title, How to Smooth    Out Accordion Lines (Smile Lines).  <\/p>\n<p>    Another star speaker was Dr Christine Dierickx, a world-wide    respected dermatologist from Skinperium, Belgium, who presented    on the Q-switched Nd:YAG-based multiplatform, SPECTRA XT,    which is the latest edition of the cutting-edge SPECTRA family    of lasers, already best-known and appreciated for its    versatility and reliability.  <\/p>\n<p>    The symposium was a great success, judging from the many    favorable comments from the attendees who were most impressed    by the practical and solid nature of the presentations and the    range of topics covered by the well-appreciated presenters.    This symposium built on the success of the similar event at    last years AMWC, and many of those present stated that they    would definitely be looking to attend again next year, hoping    that it will become a tradition to be established by Lutronic    at subsequent AMWC meetings.  <\/p>\n<p>    About ACTION II Petit Lady    The Lutronic ACTION Petit Lady is a 360 solution for cosmetic    gynecology. The treatment is gentle, simple and fast. The    ACTION II Petit Lady 360 handpiece is specially designed for    VRS. It delivers multiple micropulses to the vaginal mucosa to    stimulate collagen remodeling and tighten the vaginal canal.    The ACTION II Petit Lady 90 handpiece is intended for SUI,    providing an enhanced thermal and shrinkage effect in the    endopelvic fascia, ligaments, and mucosal tissue of the    anterior vaginal canal.  <\/p>\n<p>    To learn more about the ACTION II Petit Lady, please visit:    <a href=\"http:\/\/www.petitlady.net\/\" rel=\"nofollow\">http:\/\/www.petitlady.net\/<\/a>  <\/p>\n<p>    About LUTRONIC    Lutronic, a leading innovator in advanced aesthetic and medical    laser and related technology, was established over 18 years ago    to bring intuitive, robust, versatile devices that are    affordable and efficacious to the worldwide medical community.    Committed to improving medicine, Lutronic partners with key    opinion leaders to advance science and ensure the efficacy of    its systems. All systems are versatile and offer multiple    setting and treatment options for customized treatments, which    optimize outcomes for a wide variety of conditions and    treatments including melasma, tattoo removal, soft tissue    incision, vascular lesions, hair removal, wrinkle reduction,    skin resurfacing, body\/facial contouring, chronic pain and    more.  <\/p>\n<p>    With a focus on physician needs and patient outcomes, Lutronic    dedicates time and funding toward the development of devices    that offer features and improvements not found in todays    market. Devoting more than 20% of revenues to R&D, Lutronic    holds more than 240 intellectual properties including current    and pending patents worldwide. With more than 250 employees    worldwide, Lutronic has offices in the US, Korea, China, Japan,    and Europe, a worldwide network of distributors, and is ever    expanding.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the original:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.prweb.com\/releases\/2015\/04\/prweb12627955.htm\/RK=0\/RS=d7SQSZDwz5PhoMVHVJ.HjUtn66Y-\" title=\"LUTRONIC&#39;s Innovative Aesthetic and Medical Products Featured at the 13th Anti-Aging Medicine World Congress\">LUTRONIC&#39;s Innovative Aesthetic and Medical Products Featured at the 13th Anti-Aging Medicine World Congress<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Fremont, CA (PRWEB) April 02, 2015 Lutronic, a leading innovator of aesthetic and medical technology, announced today that it expands its portfolio of innovative medical solutions in Europe with ACTION II Petit Lady at the 13th Anti-Aging Medicine World Congress (AMWC) in Monte-Carlo, Monaco, from March 26-28, 2015.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/anti-aging-medicine\/lutronics-innovative-aesthetic-and-medical-products-featured-at-the-13th-anti-aging-medicine-world-congress.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577503],"tags":[],"class_list":["post-253341","post","type-post","status-publish","format-standard","hentry","category-anti-aging-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/253341"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=253341"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/253341\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=253341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=253341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=253341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}